Pfizer's COVID-19 Vaccine Commercialization Plan Includes DTC Campaign
The company is planning a direct-to-consumer education campaign to inform the public about the importance of vaccination.
You may also be interested in...
Missteps on convalescent plasma and the revoked authorization of hydroxychloroquine – paired with US president Trump’s cheerleading for the rapid approval of a COVID-19 vaccine – has eroded public trust in the US FDA. Can a safety and efficacy pledge from vaccine developers tamp down public skepticism?
The company showcased its pipeline in a two-day virtual meeting, trying to convince investors the long-term potential is undervalued.
Clearance by UK regulator allows trial to restart, with pivotal US trial hoped to follow suit to keep AstraZeneca and Oxford's candidate on track for a potential late 2020 readout. Plus, new results with Sinovac's vaccine in the elderly and progress with antibodies.